These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7584910)

  • 61. Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls.
    Westhuyzen J; Saltissi D; Healy H
    Atherosclerosis; 1997 Mar; 129(2):199-205. PubMed ID: 9105562
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.
    Rachmani R; Levi Z; Zadok BS; Ravid M
    Clin Pharmacol Ther; 2002 Sep; 72(3):302-7. PubMed ID: 12235451
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of cacao liquor polyphenols on the susceptibility of low-density lipoprotein to oxidation in hypercholesterolemic rabbits.
    Osakabe N; Natsume M; Adachi T; Yamagishi M; Hirano R; Takizawa T; Itakura H; Kondo K
    J Atheroscler Thromb; 2000; 7(3):164-8. PubMed ID: 11480458
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low-density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers.
    Siekmeier R; Wülfroth P; Wieland H; Gross W; März W
    Clin Chem; 1996 Apr; 42(4):524-30. PubMed ID: 8605668
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Syzygium cumini leaf extract inhibits LDL oxidation, but does not protect the liproprotein from glycation.
    Dos Santos MM; Prestes AS; de Macedo GT; Ecker A; Barcelos RP; Boligon AA; Souza D; de Bem AF; da Rocha JBT; Barbosa NV
    J Ethnopharmacol; 2018 Jan; 210():69-79. PubMed ID: 28844679
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Short-term treatment with low-dose pravastatin attenuates oxidative susceptibility of low-density lipoprotein in hypercholesterolemic patients.
    Chen MF; Hsu HC; Lee YT
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):787-93. PubMed ID: 9512874
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease.
    Karmansky I; Shnaider H; Palant A; Gruener N
    Clin Biochem; 1996 Dec; 29(6):573-9. PubMed ID: 8939406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
    Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients.
    Sundaram V; Hanna AN; Lubow GP; Koneru L; Falko JM; Sharma HM
    Am J Med Sci; 1997 Nov; 314(5):303-10. PubMed ID: 9365332
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein.
    Kleinveld HA; Hak-Lemmers HL; Stalenhoef AF; Demacker PN
    Clin Chem; 1992 Oct; 38(10):2066-72. PubMed ID: 1394991
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro effects of a flavonoid-rich extract on LDL oxidation.
    Viana M; Barbas C; Bonet B; Bonet MV; Castro M; Fraile MV; Herrera E
    Atherosclerosis; 1996 Jun; 123(1-2):83-91. PubMed ID: 8782839
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
    Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
    Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation.
    Whitman SC; Miller DB; Wolfe BM; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1707-15. PubMed ID: 9327767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of calcium channel blockers on proteoglycan synthesis by vascular smooth muscle cells and low density lipoprotein--proteoglycan interaction.
    Vijayagopal P; Subramaniam P
    Atherosclerosis; 2001 Aug; 157(2):353-60. PubMed ID: 11472734
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
    Jialal I; Grundy SM
    Circulation; 1993 Dec; 88(6):2780-6. PubMed ID: 8252691
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
    Maor I; Hayek T; Coleman R; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of flavonoids on the susceptibility of low-density lipoprotein to oxidative modification.
    Safari MR; Sheikh N
    Prostaglandins Leukot Essent Fatty Acids; 2003 Jul; 69(1):73-7. PubMed ID: 12878454
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fish oil lowers plasma lipid concentrations and increases the susceptibility of low density lipoprotein to oxidative modification in healthy men.
    Tsai PJ; Lu SC
    J Formos Med Assoc; 1997 Sep; 96(9):718-26. PubMed ID: 9308326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.